sb 203580 has been researched along with imiquimod in 1 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (imiquimod) | Trials (imiquimod) | Recent Studies (post-2010) (imiquimod) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,264 | 284 | 1,963 |
| Protein | Taxonomy | sb 203580 (IC50) | imiquimod (IC50) |
|---|---|---|---|
| Histamine H2 receptor | Homo sapiens (human) | 1.506 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 2.621 | |
| Adenosine receptor A2a | Homo sapiens (human) | 5.32 | |
| 7,8-dihydro-8-oxoguanine triphosphatase | Homo sapiens (human) | 0.646 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, M; Hu, R; Huang, G; Li, H; Liu, H; Liu, X; Liu, Y; Otsu, K; Xiao, S; Zhao, W; Zheng, T | 1 |
1 other study(ies) available for sb 203580 and imiquimod
| Article | Year |
|---|---|
p38α signaling in Langerhans cells promotes the development of IL-17-producing T cells and psoriasiform skin inflammation.
Topics: Animals; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Imidazoles; Imiquimod; Inflammation; Interleukin-17; Interleukin-23; Interleukin-6; Langerhans Cells; Mice, Inbred C57BL; Mice, Transgenic; Mitogen-Activated Protein Kinase 14; Psoriasis; Pyridines; Signal Transduction; Skin; T-Lymphocytes; Th17 Cells | 2018 |